Research Area
PRDM5-MAGL-2-AG-CB1R pathway in the DLS regulates ketamine addiction
Proposed model illustrating winning experiences affect mesocorticolimbic pathways to modify METH-seeking behavior
Introduction of PI
Wei Xu, an Associate Professor of Research at Shenzhen University of Advanced Technology, serves as a drug and medical device review expert for the Shenzhen Market Supervision and Regulation Bureau. Dr. Xu has been granted by in several national, provincial, and municipal research projects and has published multiple papers as the first author or corresponding author in prestigious journals, including Nature Communications, Journal of Neuroscience, and Neuroscience Bulletin.
Research Area
Dr. Xu research focuses on the molecular mechanisms and intervention strategies for neuropsychiatric disorders, with particular attention to the molecular mechanisms of Alzheimer's disease caused by exogenous compounds and drug addiction. She employs cutting-edge technologies such as metabolomics, single-cell sequencing, two-photon calcium imaging, and the Cre-Loxp system to investigate the intricate neurobiological mechanisms of drug addiction and the pathogenesis of neurodegenerative diseases like Alzheimer's, aiming to develop novel therapeutic strategies.
